![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Greenhouse | LSE:GHF | London | Ordinary Share | GB00B0T2CP59 | PARTCIPATING SHS NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.625 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3891F Greenhouse Fund Limited (The) 29 June 2006 For immediate release 29 June 2006 The Greenhouse Fund Limited ("Greenhouse" or "the Company") Licence Acquisitions THE GREENHOUSE FUND ACQUISITION OF BAUXSOL SUB-LICENSES AND OTHER TECHNOLOGIES FROM VIROTEC INTERNATIONAL Greenhouse today announces the acquisition of five Bauxsol technology sub-licences and the purchase of the assets of Sterling Environmental Solutions (together the "Transaction") from Virotec International Ltd ("Virotec"). It is intended that Brian Sheeran, Virotec Executive Chairman, be appointed to the board of Greenhouse to oversee commercialisation of these technologies. The aggregate consideration for the above transactions is #5 million, to be satisfied by the issue of 30,000,000 new shares in Greenhouse ("Shares") and a further #500,000 in cash. At the opening price on 29 June 2006 of 15p, the Share element is valued at #4,500,000. As a result of the issue of the Shares, Virotec will have a 19 per cent. holding in the voting share capital of Greenhouse. An application has today been made for the Shares to be admitted to trading on AIM and it is expected that the Shares will be admitted to trading on 5 July 2006. Background to the Transaction The five technologies being sub-licenced to Greenhouse are Bauxsol platform technologies developed by Virotec. These are: (a) ViroConcrete Technology, speciality cement products with applications in shotcreteing, grouting, high density concrete, acid exposed concrete or concretes that are exposed to water or wet environments, particularly salt water environments; (b) ViroAirFilter Technology, designed to remove mercury, CO2 and other polluting metals from industrial flue gasses by 'gas scrubbing' such environmentally hazardous compounds from waste gases prior to their release into the atmosphere; (c) ViroFertiliser Technology, aims to control the level of phosphate pollution and increase crop yields via the slow release of phosphate from superphosphate fertilisers; (d) Gastric animal applications; aims to relieve chronic and potentially life threatening gastric problems within animals; and (e) Any further new commercial applications developed from the Bauxsol technology; giving Greenhouse access to the time and efforts of the two main scientists, their facilities and staff involved in the development of Bauxsol and its applications in the Southern Cross University in New South Wales, Australia. The intellectual property rights of the above technologies are either held directly by the Virotec Group or licensed to it by Nauveau Technology Investments Limited, a company outside the Virotec Group and is ultimately owned by either Nauveau Technology Investments Ltd or another entity, Mount Aspiring Geochemistry Limited, a company outside the Virotec Group. Greenhouse has established a wholly-owned subsidiary company, Greenhouse IP Development Limited, to hold the sub-licences and to develop the related technologies. The strategy is to further develop the technologies, using both academic and commercial partners from within industry. Once an application has been fully commercialised, Greenhouse will consider the strategic options available to maximise shareholder value. Such alternatives include introducing a new structure for each license, depending on the particular market and opportunity that it faces. In addition, as part of the Transaction, Greenhouse has, through another wholly owned subsidiary (Greenhouse Organic Solutions Limited), purchased the assets of Sterling Environmental Solutions Ltd ("Sterling"), a UK non-trading company with a view to establishing a regional treatment centre ("RTC") for the treatment of high strength organic waste streams. The assets acquired include all intellectual property rights owned or used by Sterling, including all rights relating to the concept for the treatment of industrial waste at a central treatment centre or RTC. Sterling has no trading revenue and has not filed any audited accounts. In addition, it is intended that Greenhouse will enter into a 12 month option to acquire the business and assets of ImperativePlus Pty Ltd, a wholly owned subsidiary of Virotec. It has been agreed in principle that Greenhouse will pay a nominal consideration on grant and on exercise of this option. Greenhouse Chairman Nigel Wray commented, "This is a very exciting transaction for Greenhouse, coming less than six months since its launch on AIM. We believe that Bauxsol is a tremendous technology and provides a platform for a range of applications; each of the applications we have licenced has the potential to become a significant business in its own right. Greenhouse will also work with Virotec and our research team to create further new Bauxsol applications. I look forward to announcing developments as Greenhouse works on the applications and partners with academic and industry research bodies to further the commercial development of these technologies." For further information please contact: Paul Gazzard, Greenhouse Advisor Ltd. Tel: 020 7355 7600 Email: pg@greenhousefund.co.uk Charles Ryland/Ben Willey Buchanan Communications Tel: 020 7466 5000 Further details of the Transaction Virotec's patented platform Bauxsol Technology has been designed to extract heavy metals, arsenic, phosphates and cyanide from water, soil and air through its bespoke re-agents, without creating any hazardous waste streams. Once treated, wastes are rendered inert or non-hazardous, and significantly easier and cheaper to either be disposed of or reused. Bauxsol re-agents neutralise acidity, bind and immobilise base metals and other elements via various chemical reactions upon coming into contact with them. Whilst Greenhouse will not acquire a licence to use the core Bauxsol Technology, it will be granted five sub-licences to develop other areas of application and Virotec has agreed to supply Greenhouse with Bauxsol materials. Due to Virotec's commercial concentration on the roll out of other applications of the Bauxsol Technology, Greenhouse has been able to enter into the five sub-licenses. Virotec's consideration for the deal is primarily in Greenhouse equity, giving Virotec a direct interest in supporting Greenhouse in the long-term in its development of the various applications. Virotec has agreed not to sell or otherwise dispose of the Shares issued to it as consideration for the Transaction for a period expiring on the first anniversary of Greenhouse's accounts being published, which is expected to be March 2008, without the consent of Greenhouse and Evolution Securities Limited save in certain limited circumstances. The sub-licences also provide that Greenhouse will pay Virotec an ongoing royalty on any revenue earned from the technologies. In addition, if any of the technologies are subsequently sold by Greenhouse, any sale will include the obligation to continue to pay royalties to Virotec and for Virotec to retain a 19 per cent. interest in the technologies for zero consideration. Detailed below are the five specific applications being: Sub-Licence 1: ViroConcrete Technology This Bauxsol application has a potential commercial market in the speciality concretes area. Following initial research by CSIRO (Commonwealth Scientific and Research organisation, Australia) and Virotec that enabled a patent application to be filed, research has continued at Queens University, Belfast under Professor Bashir. This is a leading department for cement and aggregates research in Europe and has won awards and achieved pier recognition for this work. Potential applications for ViroConcrete products include shotcreteing, grouting, high density concrete, acid exposed concrete or concretes that are exposed to water or wet environments, particularly salt water environments. Greenhouse will continue to develop this technology with a view to full commercial realisation. Following further proposed research and collaboration with Queens University, Greenhouse will increase commercial and sales support as the concrete market gains awareness of the products and their potential. The long term aim is for ViroConcrete products to be recognised as the default product for particular concrete applications and therefore become an industry standard. Sub-licence 2: ViroAirFilter Technology This Bauxsol application, which has progressed in collaboration with the US Environmental Protection Agency, has been primarily focussed on the removal of mercury and Co2 from industrial flu gases. With these 'gas scrubbing' applications ViroAirFilter Technology can remove environmentally hazardous pollutants from waste gases prior to their release into the atmosphere. The results to date indicate that there is significant removal of both mercury and Co2 from industrial exhaust gases when they are allowed to pass through a bed of a specific ViroAirFilter product. There is potentially a large commercial market for these products. The next stage is to undertake a more wide reaching study, in conjunction with a specialist academic body. Sub-licence 3: ViroFertiliser Technology This Bauxsol application aids phosphate pollution control and has the potential to increase crop yields. Currently, large amounts of phosphate fertiliser are applied to farm-land, with significant proportions washed from the soil by rain, meaning poor utilisation of the fertiliser and contamination of local water. A ViroFertiliser re-agent is added to the fertiliser material once mixed with the phosphate fertiliser. It binds with the phosphate, keeping it in situ, thus decreasing the fertiliser run off, water pollution and provides the user with the opportunity to achieve greater value from the fertiliser. Tests have shown there was a significant improvement in crop yields when the ViroFertiliser Technology was used with fertiliser on, amongst others, cotton crops in Australia. The next stage in the development is a combined study, carried out by an internationally recognised research organisation to show the combined effect of the product in its target application. A well known European agricultural college is interested in carrying out this study. The results will be used to raise the profile of ViroFertiliser within the industry. Greenhouse will then approach chemical companies to bring the product through to the point of commercialisation and roll out. Sub-licence 4: Animal Gastric Applications This Bauxsol application alleviates gastric ailments within animals. A patent application has been filed for the application of the material in these areas. Demonstration and proving work indicating the potential for a product has already been carried out on horses. This represents a very interesting application of the material for the large commercial market of animal gastric problems. Greenhouse will select an academic institution to do further tests on other species before introducing the product to commercial end users. Sub-licence 5: Further Bauxsol applications This licence gives Greenhouse the right to continue the development of further applications of the Bauxsol Technology that are not currently subject to commercialisation activities by Virotec into other target markets. In addition, Greenhouse will have access to the time and efforts of the R&D scientists, their facilities and staff involved with the development of Bauxsol and its applications in the Southern Cross University in New South Wales, Australia. Sterling The assets of Sterling, which is a dormant non-trading company are being acquired pursuant to a potential opportunity to develop an existing dormant biological treatment plant in the North of England (which does not form part of Sterling's assets) with a technology retro-fitted to the site and to operate the site as a third party treatment centre for high strength organic wastes. The IPPC permit required from the UK Environment Agency to operate the site has been agreed to but not issued and this is likely to take approximately 4 months, which is considerably quicker than normal. Greenhouse is in negotiations to acquire the license for the retro-fitted technology. The existing IP licensor for the technology is in favour of its use and licensing it for the site. Greenhouse has considerable first hand knowledge of the RTC market and believes collaboration with a landfill operator partner would further enhance the credibility of the project and it is Greenhouse's intention to seek such a partner following the acquisition of the IP license. Directors' and other Interests Nigel Wray, through PIHL Equity LLP, is deemed to be interested in 7.3 per cent of the issued share capital of Virotec and 13.97 per cent of the issued share capital of Greenhouse. In accordance with the Articles of Association of Greenhouse, whilst he endorses the Transaction, he has not voted on the board resolution to approve the Transaction. It is intended that Brian Sheeran, will join the board of Greenhouse. Brian Sheeran, is a director of, and beneficially interested in, 2.9 per cent. of the share capital of Virotec. Virotec has a 33.64 per cent holding in Hydrodec Group plc ("Hydrodec") and Brian Sheeran is also on the board of Hydrodec, together with fellow Virotec director, Bruno Bamonte. Rodger Sargent, who is a director and shareholder of Greenhouse Advisor Limited, the Strategic Adviser to Greenhouse's Investment Adviser, is the finance director of, and also a shareholder in, Hydrodec. Valuation of the Transaction The five Bauxsol technologies being sub-licensed and Sterling are at relatively early stages of development and all require investment to bring to full commercial realisation. This makes them subjective to value, as they are novel applications of a relatively new technology. However, given the size of the target markets for each of the technologies, the Directors of Greenhouse believe they have significant commercial potential. Given this, Greenhouse has valued each of the Bauxsol sub-licenses at #1,000,000 each, to reflect their potential and the requirement for additional cash and management investment. The business and assets of Sterling are not considered to carry a quantifiable valuation at this stage, so have been valued at a nominal #1. This provides a valuation of #5,000,000. The valuation also takes into account the 19 per cent. equity interest and royalties which Virotec will receive in any vehicle that any sub-licensed technology is subsequently sold to. Rationale for the Transaction Greenhouse considers this to be a very good opportunity for the Company to acquire licensed technology of potentially significant commercial value. This licensed intellectual property should allow Greenhouse to populate its deal pipeline with a platform technology that has the potential to provide many applications in the future. The Bauxsol platform technology has already achieved commercial and regulatory recognition and has already had significant development capital invested in it by Virotec. Greenhouse will benefit from this proving work and has the opportunity to further develop the technology into new and as yet commercially untapped areas. Greenhouse considers that the applications; including speciality concrete products, fertiliser applications, gas scrubbing and stomach acid treatment in animals have all had sufficient work done to demonstrate the potential for each one to become, in time, the platform for a substantive business. The deal structure should ensure that the interests of Greenhouse and Virotec are aligned in working towards the common goal of successfully commercialising the intellectual property and business being acquired by Greenhouse. The Sterling platform has the potential to offer an alternative to landfill in the disposal of high strength organic wastes and be rolled out across the UK and Europe. For Greenhouse, the Transaction has significant potential and brings with it support from an established high profile operator in the sustainability sector as well as the ability to generate its own intellectual property from a platform technology in the future. This information is provided by RNS The company news service from the London Stock Exchange END MSCPUURGQUPQGWB
1 Year Greenhouse Fund Chart |
1 Month Greenhouse Fund Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions